I-Lopid (gemfibrozil) imithi ephuza i-lipid eyingxenye yezidakamizwa ze- fibrate . I-Lopid isetshenziselwa ukunciphisa i-lipids - ikakhulukazi lapho kunamazinga aphakeme kakhulu e-triglyceride lapho ingozi yokuhlaselwa kwe-pancreatitis yanda. Ngaphezu kwalokho, ucwaningo luye lwabonisa ukuthi i-Lopid inganciphisa futhi ingozi yesifo senhliziyo kubantu abano-primary dyslipidemia.
Esinye isifundo, izifo ze-coronary heart zanciphisa ngamaphesenti angama-34 kubantu abathatha i-Lopid. Ucwaningo luye lwabonisa ukuthi i-Lopid inomphumela olandelayo kuphrofayela yakho ye-lipid:
- I- cholesterol ye- LDL inciphisa ngokwesilinganiso sama-25%
- Amazinga ephelele we-cholesterol anciphisa ngokwesilinganiso sama-13%.
- I-Triglycerides incishiswa yi-50%.
- Amazinga we- HDL e- cholesterol akhuliswa ngokwesilinganiso sama-13%.
I-Lopid yavunyelwa ukusetshenziswa e-United States yi-Food and Drug Administration (FDA) ngoDisemba ka-1981.
I-Lopid Isebenza Kanjani?
I-Lopid isebenza ngokunciphisa inani le-triglycerides elikhiqizwa yisibindi. Isidakamizwa sibonakala futhi sivimbela ukusungula futhi sikhulise ukususwa kwe-apolipoprotein B, isithwala se-VLDL. Lokhu kuzokwehlisa izinga le-VLDL emzimbeni.
Kufanele i-Lopid kufanele ithathwe kanjani?
I-Lopid kufanele ithathwe ngomlomo, i-tablet eyodwa engu-600 mg ethathwe ekuseni kanye neyodwa i-tablet ye-600 mg ethathwe kusihlwa.
I-Lopid kufanele ithathwe okungenani imizuzu engu-30 ngaphambi kokudla. I-Lopid kufanele ithathwe kanye nokudla kwe-lipid-downing.
Ubani Ongayithathi I-Lopid?
Uma unezinye zezimo zezokwelapha ezibalwe ngezansi, akufanele uthathe i-Lopid. Kulezi zimo, umhlinzeki wezempilo wakho anganquma ukukubeka ekwelapheni okuhlukile ukwehlisa lipids yakho:
- Ukungezwani komzimba ku-Lopid . Uma ngabe uke wangena ku-Lopid noma ngabe iyiphi ingxenye yayo, akufanele uthathe i-Lopid.
- Isifo se-Gallbladder . Uma unomlando wesifo se-gallbladder, akufanele uthathe le mithi. Ekucwaningweni, abantu abathatha i-Lopid babhekene nokwanda okuphawulekayo ekukhuleni kwesifo se-gallbladder, kuhlanganise nezigulane, okudingeka ukuba kwenziwe ukuhlinzwa.
- Isifo sesibindi. Ukuhlolwa kwe-enzyme yesibindi engavamile kuphawulwe lapho kuthatha i-Lopid. Ngakho uma unesifo sesibindi, kuhlanganise ne-cirrhosis eyinhloko yebhayari, akufanele uthathe i-Lopid.
- Isifo sezinso. Abantu abanesifo esinzima sezinso akufanele bathathe i-Lopid ngoba kungase kube nzima ukusebenza kwezinso.
- Ukuthatha i-Repaglinide. Uma uthatha i-repaglinide yemithi yesifo sikashukela, ukuthatha i-Lopid nayo kungandisa ama-repaglinide egazini lakho. Ngakho-ke, akufanele uthathe i-Lopid uma usuvele uthatha le mithi.
Ukwengeza, i-Lopid iyisigaba sokukhulelwa C. Akukaze kube khona izifundo eziningi ezihlolisisa umphumela we-Lopid kumntanakho. Kodwa-ke, ezinye izifundo zogwaja nezikhuni ezikhulelwe zibonise ukwanda kwezifo ezingavamile kanye nokuzalwa kwezintambo lapho kuthatha umthamo womuntu we-Lopid izikhathi ezintathu.
Ngaphezu kwalokho, aziwa ukuthi i-Lopid iboniswa ubisi lwebele. Ngakho-ke, uma ukhulelwe noma uhlengikazi, kufanele ukhulume nomhlinzeki wakho wezempilo ngaphambi kokuthatha le mithi. Uyobe esilinganisa izinzuzo empilweni yakho ngokuphathelene nengozi engenzeka enganeni yakho engakazalwa.
Yiziphi izinhlobo zemizamo engezansi ezokwenza i-Lopid?
Imiphumela emibi kakhulu ethintekayo ngenkathi ithatha i-Lopid ihlanganisa:
- Ukuguquka kwenhliziyo
- Ubuhlungu besisu
- Uhudo
- Ukuqokwa
- Izinwele
- Isizungu
- Rash
- I-fibrillation ye-Atrial
Ekucwaningweni, le miphumela emibi yayisesikhashana nje futhi yahamba ngokulashwa okuqhubekayo, f ubhekene nanoma yimiphi imiphumela emibi evela eLipid, kufanele ukhulume nomhlinzeki wakho wezempilo - ikakhulukazi uma bekhathazeka noma bengashiyi.
Zikhona yini Imithi Engahle Isebenze ne-Lopid?
Kunemithi embalwa engaxhumana no-Lopid. Uma uthatha enye yale mithi, umhlinzeki wakho wezempilo anganquma ukuguqula umthamo wakho noma akubeke emithini ehlukile ukuze unciphise amazinga akho e-lipid:
- Anticoagulants. Ukuthatha i-anticoagulants, njenge-Coumadin (i-warfarin), ne-Lopid ingakwenza ube negazi kalula. Umhlinzeki wakho wezempilo uzokuqapha ngezikhathi ezithile imithi yakho futhi angayishintsha njengoba kudingeka.
- Izitatimende. Ukuthatha i-statin - ngaphezu kwe-Lopid - ukwehlisa amazinga akho e-lipid kungandisa ingozi yakho ye- rhabdomyolysis . Le mithi inganikezwa ndawonye ngenxa yenzuzo yabo engaba khona empilweni yakho yezempilo, kodwa umhlinzeki wakho wezezempilo uzoqapha ukwelashwa kwakho ukuqinisekisa ukuthi awunayo imiphumela emibi evela enhlanganisweni.
- Ama-resine ama-acid. Ukuthatha i-resin acid i-resin kunganciphisa inani le-Lopid elingene emzimbeni, okunganciphisa ukusebenza kwalo. Umhlinzeki wakho wezempilo uyokwazi ukuba uthathe le mithi emibili ngezikhathi ezahlukene zosuku ukuvimbela lokhu kusebenzisana.
Lokhu akulona uhlu oluphelele. Kufanele uvumele umhlinzeki wakho wezempilo ukuthi azi yonke imithi oyithatha ngenkathi ethatha i-Lopid. Lokhu kuzosiza umhlinzeki wakho wezokunakekelwa kwempilo ukuthi akuqaphele ukusebenzisana kwezidakamizwa lapho uthola imithi.
Okubalulekile
I-Lopid yayiyi-fibrate yokuqala evunyelwe ukusetshenziswa e-United States. I-Lopid isetshenziswa ngokuyinhloko ukwehlisa amazinga ka-triglyceride kodwa ingahle ihlanganiswe nesimiso se-statin noma i-bile acid lapho kwenzeka khona ukuthi i-LDL cholesterol iyancishiswa. Akukho umehluko omkhulu phakathi kweLipid kanye ne-fibrate evunyelwe kamuva, iTricor. Kodwa-ke, kubonakala sengathi kubambene ukusebenzisana kwezidakamizwa no-Tricor (kufisa ukufiphaza) futhi kunomphumela ophansi we-rhabdomyolysis ehambisana no-Tricor.
Imithombo:
I-LOPID [iphakheji efakiwe]. I-Parke-Davis Pharmaceuticals: New York, NY, 9/2010
I-Micromedex 2.0. I-Truven Health Analytics, Inc. I-Greenwood Village, CO. Itholakala ku-: http://www.micromedexsolutions.com. Ifinyelele ngo-Februwari 10, 2016